Furthermore, FGF-23 counteracted the beneficial effect of paricalcitol on left ventricular hypertrophy, by modulation of the calcineurin/nuclear factor of activated T cell (NFAT) pathway in a rat model of CKD (Czaya et al., 2019). This evidence concerns the gene FGF23 and chronic kidney disease.